In conclusion the results presented here suggest that, among the multiple pathways that are activated in NSCLC, aberrant PI3K/Akt signalling contributes to promote and/or maintain NSCLC TICs by eliciting an autocrine IL-6/IL-6r loop that activates the transcription factor STAT3. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.